Detailed answers about THERAPY SESSION ATHLETICS LTD, including incorporation, status, business activity, and accounts information.
When was THERAPY SESSION ATHLETICS LTD founded?
THERAPY SESSION ATHLETICS LTD was officially incorporated on 7 June 2024 and is registered under company number 15768103. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is THERAPY SESSION ATHLETICS LTD?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of THERAPY SESSION ATHLETICS LTD?
THERAPY SESSION ATHLETICS LTD's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does THERAPY SESSION ATHLETICS LTD do?
THERAPY SESSION ATHLETICS LTD operates in the following sector: 93199 - Other sports activities. This provides insight into the company's primary business activity and industry focus.
What is THERAPY SESSION ATHLETICS LTD's registered address?
The registered office address of THERAPY SESSION ATHLETICS LTD is 23 AXHOLME DRIVE, EPWORTH, DONCASTER, ENGLAND, DN9 1EL. This is the official address filed with Companies House for legal and statutory correspondence.
Is THERAPY SESSION ATHLETICS LTD financially stable?
Financial accounts for THERAPY SESSION ATHLETICS LTD are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.
Has THERAPY SESSION ATHLETICS LTD changed its name?
Yes, THERAPY SESSION ATHLETICS LTD has had 1 previous name: THERAPY SESSION SUPPLEMENTS LTD (changed 9 July 2024).